Up-regulation of LRP16 mRNA by 17β-estradiol through activation of estrogen receptor α (ERα), but not ERβ, and promotion of human breast cancer MCF-7 cell proliferation: A preliminary report

Endocrine-Related Cancer

Volumn 10, Issue 2, 2003, Pages 217-224

  Han, W D ^a   Mu, Y M ^a   Lu, X C ^a   Xu, Z M ^a   Li, X J ^a   Yu, L ^a   Song, H J ^a   Li, M ^a   Lu, J M ^a   Zhao, Y L ^a   Pan, C Y ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; CYCLIN E; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; LUCIFERASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P21; PROTEIN P53; TRYPAN BLUE; UNCLASSIFIED DRUG;

BREAST CANCER; CELL CULTURE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL STRAIN COS7; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ASSAY; FEMALE; FLOW CYTOMETRY; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LRP16 GENE; LYMPHOCYTE; MOLECULAR CLONING; NORTHERN BLOTTING; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; COS CELLS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; RECEPTORS, ANDROGEN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RESPONSE ELEMENTS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0037937509     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0100217     Document Type: Conference Paper

References (36)

1. Ali S & Coombes RC 2000 Estrogen receptor alpha in human breast cancer: occurrence and significance. Journal of Mammary Gland Biology and Neoplasia 5 271-281.
2. Bates SE, Davidson NE, Valverius EM, Freter CE, Dickson RB, Tam JP, Kudlow JE, Lippman ME & Salomon DS 1988 Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance. Molecular Endocrinology 2 543-555.
3. Batistuzzo de Medeiros SR, Krey G, Hihi AK & Wahli W 1997 Functional interaction between the estrogen receptor and the transcription activator Sp1 regulate the estrogen-dependent transcriptional activity of the vitellogenin A1 promoter. Journal of Biological Chemistry 272 18250-18260.
4. Brys M, Wojcik M, Romanowicz-Makowska H & Krajewska WM 2002 Androgen receptor status in female breast cancer: RT-PCR and Western blot studies. Journal of Cancer Research and Clinical Oncology 128 85-90.
5. Chappell J, Leitner JW, Solomon S, Golovchenko I, Goalstone ML & Draznin B 2001 Effect of insulin on cell cycle progression in MCF-7 breast cancer cells. Direct and potentiating influence. Journal of Biological Chemistry 276 38023-38028.
6. Ellis LM, Wittliff JL, Bryant MS, Hogancamp WE, Sitren HS & Bland KI 1989 Correlation of estrogen, progesterone and androgen receptors in breast cancer. American Journal of Surgery 157 577-581.
7. Galienand WJ & Garcia T 1997 Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Research 25 2424-2429.
8. Gradishar WJ & Jordan VC 1997 Clinical potential of new antiestrogens. Journal of Clinical Oncology 15 840-852.
9. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P & Chambon P 1986 Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 134-139.
10. Gustafsson J-A & Warner M 2000 Estrogen receptor beta in the breast: role of estrogen responsiveness and development of breast cancer. Journal of Steroid Biochemistry and Molecular Biology 74 245-248.
11. Han WD, Yu L, Lou FD, Wang QS, Zhao Y, Shi ZJ, Jiao HY & Zhou JJ 2001a Cloning and expression characterization of the full length cDNA for a novel leukemia-associated gene LRP16. Academic Journal of PLA Postgraduate Medical School 17 209-214.
12. Han WD, Yu L, Lou FD, Wang QS, Zhao Y, Shi ZJ & Jin HJ 2001b The application of RACE technique to clone the full length cDNA of a novel leukemia-associated gene LRP16. Chinese Journal of Experimental Hematology 9 18-21.
13. Han WD, Lou FD, Yu L, Wang QS, Han XP & Li XJ 2002 SAGE pattern of LRP16 gene and its expression in normal blood and leukemic cells. Academic Journal of PLA Postgraduate Medical School 23 161-163.
14. Huang M, Yang S, Liao S, Zhang B & You J 2000 The effects of cyclin E on the growth and other cell cycle related genes of breast carcinoma cells MCF-7. Zhonghua Bing Li Xue Za Zhi 29 192-195.
15. Huynh H, Yang X & Pollak M 1996 Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cell. Journal of Biological Chemistry 271 1016-1021.
16. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D & Chambon P 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494.
17. Katzenellenbogen BS & Katzenellenbogen JA 2000 Estrogen receptor transcription and transactivation. Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Research and Treatment 2 335-344.
18. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R & Dickson RB 1987 Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48 417-428.
19. Knowlden JM, Gee JM, Robertson JF, Ellis IO & Nicholson RI 2000 A possible divergent role for the oestrogen receptor alpha and beta subtypes in clinical breast cancer. International Journal of Cancer 89 209-212.
20. Kuenen-Boumeester V, Van der Kwast TH, van Putten WL, Claassen C, van Ooijen B & Henzen-Logmans SC 1992 Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer. International Journal of Cancer 52 581-584.
21. Mu YM, Yanase T, Nishi Y, Tanaka A, Saito M, Jin CH, Mukasa C, Okabe T, Nomura M, Goto K & Nawata H 2001 Saturated FFAs, palmitic acid and stearic acid induce apoptosis in human granulosa cells. Endocrinology 142 3590-3597.
22. Osborne KC, Schiff R, Fuqua SAW & Shou J 2001 Estrogen receptor: current understanding of its activation and modulation. Clinical Cancer Research 7 4338s-4342s.
23. Paech K, Webb P, Kuiper GG, Nilsson S, Gustafsson J-A, Kushner PJ & Scalan TS 1997 Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277 1508-1510.
24. Palmieri C, Cheng GJ, Saji S, Zelada-Hedman M, Warri A, Weihua Z, Van Noorden S, Wahlstrom T, Coombes RC, Warner M & Gustafsson J-A 2002 Estrogen receptor beta in breast cancer. Endocrine-Related Cancer 9 1-13.
25. Porter W, Saville B, Hoivik D & Safe S 1999 Functional synergy between the transcription factor Sp1 and the estrogen receptor. Molecular Endocrinology 11 1569-1580.
26. Russo J, Tahin Q, Lareef MH, Hu YF & Russo IH 2002 Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens. Environmental and Molecular Mutagenesis 39 254-263.
27. Safe S 2001 Transcriptional activation of genes by 17beta-estradiol through estrogen receptor-Sp1 interactions. Vitamins and Hormones - Advances in Research and Applications 62 231-252.
28. Santen RJ 2002 To block estrogen's synthesis or action: that is the question. Journal of Clinical Endocrinology and Metabolism 87 3007-3012.
29. Santen RJ & Harvey HA 1999 Use of aromatase inhibitors in breast cancer. Endocrine-Related Cancer 6 75-92.
30. Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH & Yue W 2002 The role of mitogen-activated protein (MAP) kinase in breast cancer. Journal of Steroid Biochemistry and Molecular Biology 80 239-256.
31. kip1 expression. Cell Growth and Differentiation 8 393-405.
32. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW & Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407 538-541.
33. Speirs V & Kerin MJ 2000 Prognostic significance of oestrogen receptor beta in breast cancer. British Journal of Surgery 87 405-409.
34. Tsai M & O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annual Review of Biochemistry 63 451-486.
35. Warner M, Saji S & Gustafsson J-A 2000 The normal and malignant mammary gland: a fresh look with ERbeta on board. Journal of Mammary Gland Biology and Neoplasia 5 289-294.
36. Yu L, Han WD, Lou FD, Wang QS & Zhao Y 2000 Cloning of leukemia associated gene LRP16 in acute myeloid leukemia. Academic Journal of PLA Postgraduate Medical School 21 81-84.